- Minors are also more likely to be vaccinated in the United States
- Decision within a few days on the permission sought by Pfizer for vaccine use
- Aim for vaccination before the start of the new academic year
Coronavirus vaccine: Efforts are underway to speed up vaccination in the United States, which has been dealing with coronary heart disease. Efforts are underway to vaccinate more and more citizens. The United States is now expected to vaccinate people between the ages of 12 and 15. The U.S. Food and Drug Administration says a decision on a vaccine developed for this age group is expected in the coming weeks. The goal will be to vaccinate most children before the start of the next academic year.
The American drug company Pfizer has developed the Coronavirus vaccine for the age group of 12 to 15 years. By the end of March, Pfizer had tested 2260 volunteers between the ages of 12 and 15. No symptoms of covid were found in children vaccinated in this test. The children who took part in the test began to experience the same side effects as adults after being vaccinated. Symptoms include chills, fatigue, and fever. The nature of the volunteers participating in this test will be monitored for at least two years. So that the safety of the vaccine can be studied.
In addition to Pfizer, Modern has also developed vaccines for minors. The vaccine developed by Modern for the age group of 12 to 17 is being tested. The results of the test are expected to be released in the coming months.
Meanwhile, the United Nations has extended a helping hand in view of the growing plight of coronary heart disease in India. According to UNICEF, India has been provided with various essential facilities, including 3,000 oxygen concentrators. Equipment required for health tests, 85 RT-PCR devices, other essential medical items, and 3,000 oxygen concentrators have been sent to India, he said. Apart from this, UNICEF is cooperating to start 25 oxygen generating projects in Maharashtra and Northeast India.